首页 > 最新文献

American Journal of Clinical Nutrition最新文献

英文 中文
Ultraprocessed food consumption by urbanization level among United States youth and adults: cross-sectional analysis of NHANES 2013–March 2020 美国青年和成年人城市化水平下的超加工食品消费:2013- 2020年3月NHANES横断面分析
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.010
Nicholas Ansai , Anne M Williams , Samuel D Emmerich , Kirsten A Herrick , Edwina A Wambogo , Euridice Martínez Steele , Cynthia L Ogden

Background

In the United States, ultraprocessed foods (UPFs) may contribute to poorer diet quality that has been observed in rural areas compared with urban areas, as increased UPF consumption is linked with decreased nutritional quality.

Objectives

To describe the mean contribution to total energy and total gram intakes from UPFs, unprocessed or minimally processed foods (MPFs), and other Nova categories and subcategories by urbanization level among United States youth and adults.

Methods

Cross-sectional data from the National Health and Nutrition Examination Survey from 2013 to March 2020 were analyzed. The mean percent of total energy and total gram intakes from Nova categories (MPFs, processed culinary ingredients, processed foods, and UPFs) were estimated by urbanization level (nonmetropolitan statistical areas [non-MSAs, n = 3976], small-to-medium MSAs [n = 9170], and large MSAs [n = 14,637]) for youth 2–19 y and adults 20 y and older. Trends by urbanization level were assessed using orthogonal contrasts in linear regression models adjusted for sex, age, race and Hispanic origin, and income. Day 1 dietary sample weights accounted for differential probabilities of selection, nonresponse, noncoverage, and day of the week.

Results

Among youth, there was no trend in MPF or UPF as a percent of energy by the urbanization level. As a percent of grams, MPF increased and UPF decreased with a higher urbanization level. After adjustment for sex, age, race and Hispanic origin, and income, only the trend in the percent of grams from MPF remained. Among adults, as both a percent of energy and a percent of grams, MPF increased and UPF decreased with higher urbanization levels. These trends remained significant after adjustment for covariates.

Conclusions

Adults in rural areas consumed more UPF and less MPF than those in urban areas in terms of both energy and grams. There were a few significant differences by urbanization among youth.
目的:描述超加工食品(UPF)、未加工或最低加工食品(MPF)、其他Nova类别和子类别在美国青年和成年人中城市化水平对总能量和总克摄入量的平均贡献。方法:对2013- 2020年3月全国健康与营养检查调查的横断面数据进行分析。根据2-19岁青年和20岁及以上成年人的城市化(非大都市统计地区(非msa, n=3,976)、中小型msa (n=9,170)和大型msa (n=14,637))估算了Nova类别(MPF、加工烹饪配料(PCI)、加工食品(PF)和UPF)的总能量和总克摄入量的平均百分比。城市化趋势采用线性回归模型的正交对比评估,调整了性别、年龄、种族/西班牙裔和收入。第1天的膳食样本权重考虑了选择、无反应、无覆盖和周中天数的不同概率。结果:在年轻人中,MPF或UPF占能源的百分比没有随城市化水平而变化的趋势。随着城市化水平的提高,强积金(MPF)增加,UPF (UPF)减少。在对性别、年龄、种族、西班牙裔和收入进行调整后,只有来自强积金的克数百分比保持不变。在成年人中,随着城市化水平的提高,能量百分比和克数百分比的MPF增加,UPF降低。在调整协变量后,这些趋势仍然显著。结论:在能量和克数方面,农村地区的成年人比城市地区的成年人消耗更多的UPF和更少的MPF。不同城市化程度的年轻人在这方面没有显著差异。
{"title":"Ultraprocessed food consumption by urbanization level among United States youth and adults: cross-sectional analysis of NHANES 2013–March 2020","authors":"Nicholas Ansai ,&nbsp;Anne M Williams ,&nbsp;Samuel D Emmerich ,&nbsp;Kirsten A Herrick ,&nbsp;Edwina A Wambogo ,&nbsp;Euridice Martínez Steele ,&nbsp;Cynthia L Ogden","doi":"10.1016/j.ajcnut.2025.10.010","DOIUrl":"10.1016/j.ajcnut.2025.10.010","url":null,"abstract":"<div><h3>Background</h3><div>In the United States, ultraprocessed foods (UPFs) may contribute to poorer diet quality that has been observed in rural areas compared with urban areas, as increased UPF consumption is linked with decreased nutritional quality.</div></div><div><h3>Objectives</h3><div>To describe the mean contribution to total energy and total gram intakes from UPFs, unprocessed or minimally processed foods (MPFs), and other Nova categories and subcategories by urbanization level among United States youth and adults.</div></div><div><h3>Methods</h3><div>Cross-sectional data from the National Health and Nutrition Examination Survey from 2013 to March 2020 were analyzed. The mean percent of total energy and total gram intakes from Nova categories (MPFs, processed culinary ingredients, processed foods, and UPFs) were estimated by urbanization level (nonmetropolitan statistical areas [non-MSAs, <em>n</em> = 3976], small-to-medium MSAs [<em>n</em> = 9170], and large MSAs [<em>n</em> = 14,637]) for youth 2–19 y and adults 20 y and older. Trends by urbanization level were assessed using orthogonal contrasts in linear regression models adjusted for sex, age, race and Hispanic origin, and income. Day 1 dietary sample weights accounted for differential probabilities of selection, nonresponse, noncoverage, and day of the week.</div></div><div><h3>Results</h3><div>Among youth, there was no trend in MPF or UPF as a percent of energy by the urbanization level. As a percent of grams, MPF increased and UPF decreased with a higher urbanization level. After adjustment for sex, age, race and Hispanic origin, and income, only the trend in the percent of grams from MPF remained. Among adults, as both a percent of energy and a percent of grams, MPF increased and UPF decreased with higher urbanization levels. These trends remained significant after adjustment for covariates.</div></div><div><h3>Conclusions</h3><div>Adults in rural areas consumed more UPF and less MPF than those in urban areas in terms of both energy and grams. There were a few significant differences by urbanization among youth.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101093"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthful dietary patterns and risks of microvascular complications among individuals with type 2 diabetes: a prospective cohort study 健康饮食模式和2型糖尿病患者微血管并发症的风险:一项前瞻性队列研究
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.005
Ruyi Li , Kun Xu , Kai Zhu , Jun Liu , Shufan Tian , Rui Li , Danpei Li , Youqiao Liao , Tingting Geng , Yunfei Liao , Kun Yang , Xuefeng Yu , An Pan , Gang Liu

Background

Diet plays a key role in diabetes management; however, evidence on healthful dietary patterns and diabetic microvascular complications is scarce.

Objectives

This study aimed to evaluate and compare associations of 8 healthful dietary pattern scores with risks of diabetic microvascular complications and explore the mediating role of circulating biomarkers.

Methods

This prospective cohort study included 6119 participants with type 2 diabetes from the UK Biobank. Dietary pattern scores were assessed based on 24-h dietary questionnaires. Diabetic kidney diseases (DKDs), diabetic retinopathy (DR), and diabetic neuropathy (DN) were identified via electronic health records. Hazard ratios (HRs) and 95% confidence intervals (CIs) were evaluated using multivariable-adjusted Cox models. Stratified analyses were performed by age group, sex, obesity status, and various medical conditions. Mediation analyses assessed the potential mediating role of 23 circulating biomarkers.

Results

During a median follow-up of 9.9 y, higher healthful dietary patterns scores were associated with lower risk of DKD, with healthful plant-based index (HPDI) demonstrating the strongest association [HR (95% CI) for highest compared with lowest quintile: 0.55 (0.43, 0.70)]. Moreover, when compared with the same reference group, HPDI remained the top-ranked dietary pattern that was strongly associated with the risk of DKD. Among 8 dietary patterns, only HPDI was associated with lower risks of DR and DN [HR (95% CI) for highest compared with lowest quintile: 0.74 (0.58, 0.96) and 0.61 (0.39, 0.95)]. Furthermore, cystatin C and C-reactive protein play a primary mediating role in these associations.

Conclusions

Higher healthful dietary pattern scores were associated with lower risk of DKD, whereas inverse associations with risks of DR and DN were mainly observed for HPDI. These associations were mainly mediated through pathways relating to renal function and inflammation.
背景:饮食在糖尿病管理中起着关键作用;然而,关于健康饮食模式和糖尿病微血管并发症的证据很少。目的:本研究旨在评估和比较8种健康饮食模式评分与糖尿病微血管并发症风险的相关性,并探讨循环生物标志物的介导作用。方法:这项前瞻性队列研究包括6119名来自英国生物银行的2型糖尿病患者。根据24小时饮食问卷对饮食模式评分进行评估。通过电子健康记录确定糖尿病肾病(DKDs)、糖尿病视网膜病变(DR)和糖尿病神经病变(DN)。采用多变量校正Cox模型评估风险比(hr)和95%置信区间(ci)。按年龄组、性别、肥胖状况和各种医疗条件进行分层分析。中介分析评估了23种循环生物标志物的潜在中介作用。结果:在中位随访9.9年期间,较高的健康饮食模式评分与较低的DKD风险相关,健康植物性指数(HPDI)显示出最强的相关性[最高五分位数与最低五分位数的HR (95% CI): 0.55(0.43, 0.70)]。此外,与相同的参照组相比,HPDI仍然是与DKD风险密切相关的排名第一的饮食模式。在8种饮食模式中,只有HPDI与较低的DR和DN风险相关[最高和最低五分位数的HR (95% CI)分别为0.74(0.58,0.96)和0.61(0.39,0.95)]。此外,胱抑素C和C反应蛋白在这些关联中起主要介导作用。结论:较高的健康饮食模式评分与较低的DKD风险相关,而与DR和DN风险负相关的主要是HPDI。这些关联主要通过与肾功能和炎症相关的途径介导。
{"title":"Healthful dietary patterns and risks of microvascular complications among individuals with type 2 diabetes: a prospective cohort study","authors":"Ruyi Li ,&nbsp;Kun Xu ,&nbsp;Kai Zhu ,&nbsp;Jun Liu ,&nbsp;Shufan Tian ,&nbsp;Rui Li ,&nbsp;Danpei Li ,&nbsp;Youqiao Liao ,&nbsp;Tingting Geng ,&nbsp;Yunfei Liao ,&nbsp;Kun Yang ,&nbsp;Xuefeng Yu ,&nbsp;An Pan ,&nbsp;Gang Liu","doi":"10.1016/j.ajcnut.2025.10.005","DOIUrl":"10.1016/j.ajcnut.2025.10.005","url":null,"abstract":"<div><h3>Background</h3><div>Diet plays a key role in diabetes management; however, evidence on healthful dietary patterns and diabetic microvascular complications is scarce.</div></div><div><h3>Objectives</h3><div>This study aimed to evaluate and compare associations of 8 healthful dietary pattern scores with risks of diabetic microvascular complications and explore the mediating role of circulating biomarkers.</div></div><div><h3>Methods</h3><div>This prospective cohort study included 6119 participants with type 2 diabetes from the UK Biobank. Dietary pattern scores were assessed based on 24-h dietary questionnaires. Diabetic kidney diseases (DKDs), diabetic retinopathy (DR), and diabetic neuropathy (DN) were identified via electronic health records. Hazard ratios (HRs) and 95% confidence intervals (CIs) were evaluated using multivariable-adjusted Cox models. Stratified analyses were performed by age group, sex, obesity status, and various medical conditions. Mediation analyses assessed the potential mediating role of 23 circulating biomarkers.</div></div><div><h3>Results</h3><div>During a median follow-up of 9.9 y, higher healthful dietary patterns scores were associated with lower risk of DKD, with healthful plant-based index (HPDI) demonstrating the strongest association [HR (95% CI) for highest compared with lowest quintile: 0.55 (0.43, 0.70)]. Moreover, when compared with the same reference group, HPDI remained the top-ranked dietary pattern that was strongly associated with the risk of DKD. Among 8 dietary patterns, only HPDI was associated with lower risks of DR and DN [HR (95% CI) for highest compared with lowest quintile: 0.74 (0.58, 0.96) and 0.61 (0.39, 0.95)]. Furthermore, cystatin C and C-reactive protein play a primary mediating role in these associations.</div></div><div><h3>Conclusions</h3><div>Higher healthful dietary pattern scores were associated with lower risk of DKD, whereas inverse associations with risks of DR and DN were mainly observed for HPDI. These associations were mainly mediated through pathways relating to renal function and inflammation.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101088"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Queries and Comment to the Article by Ichikawa et al. 对Ichikawa等人的文章的查询和评论。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.025
Masato Takeuchi
{"title":"Queries and Comment to the Article by Ichikawa et al.","authors":"Masato Takeuchi","doi":"10.1016/j.ajcnut.2025.10.025","DOIUrl":"10.1016/j.ajcnut.2025.10.025","url":null,"abstract":"","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101111"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145876755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Sweet Tooth Trial: A Parallel Randomized Controlled Trial Investigating the Effects of A 6-Month Low, Regular, or High Dietary Sweet Taste Exposure on Sweet Taste Liking, and Various Outcomes Related to Food Intake and Weight Status 甜食试验:一项平行随机对照试验,调查6个月低、常规或高饮食甜食对甜食喜好的影响,以及与食物摄入和体重状况相关的各种结果
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.09.041
Eva M Čad , Monica Mars , Leoné Pretorius , Merel van der Kruijssen , Claudia S Tang , Hanne BT de Jong , Michiel Balvers , Katherine M Appleton , Kees de Graaf

Background

Public health organizations currently recommend lowering the consumption of sweet-tasting foods, on the assumption that a lower exposure to sweet-tasting foods lowers preferences for sweet taste, decreasing sugar and energy intake, and aiding obesity prevention. However, empirical data supporting this narrative are lacking.

Objectives

The objective of this study was to assess the effects of a 6-mo low, regular, and high dietary sweet taste exposure on liking for sweet taste.

Methods

In a parallel-groups randomized controlled intervention study, 180 healthy adults (female/male: 123/57; aged: 35 ± 15 y; body mass index (in kg/m2): 23 ± 3) were provided with dietary advice and ∼50% daily energy needs for 6 mo, where 7% (low sweet taste exposure, n = 61), 35% (regular sweet taste exposure, n = 60), or 80% (high sweet taste exposure, n = 59) provided foods and beverages were sweet tasting from sugars, low-calorie sweeteners, fruits and dairy. Before, at 6 mo, and at a 4-mo follow-up, sweet taste liking, sweet taste intensity perception, food choice, energy intake, body weight, markers for diabetes and cardiovascular disease, and adverse events were assessed.

Results

Sweet food consumption varied between groups over the intervention period (self-reported dietary measures (percentage energy, percentage weight): smallest χ2(16) = 59.4, P < 0.001; urinary markers for sucrose, sucralose, and saccharin: smallest χ2(10) = 21.0, P = 0.02). However, from baseline to month 6, no differences between groups were found in sweet taste liking ( χ2(40) = 37.9, P = 0.56), sweet taste intensity perception (χ2(40) = 20.7, P = 0.99), sweet food choice (χ2(10) = 10.1, P = 0.43), energy intake (χ2(10) = 12.7, P = 0.24), body weight (χ2(10) = 14.3, P = 0.16), markers for diabetes and cardiovascular disease (largest χ2(10) = 15.9, P = 0.10) or adverse events. After the intervention, participants also spontaneously returned to baseline levels of sweet food intake.

Conclusions

In the current trial, altering exposure to sweet-tasting foods did not change sweet taste liking, nor other outcomes. These results do not support public health advice to reduce exposure to sweet-tasting foods, independent of other relevant factors such as energy density and food form.
This trial was registered at clinicaltrials.gov as NCT04497974.
公共卫生组织目前建议减少甜味食品的消费,假设较少接触甜味食品会降低对甜味的偏好,减少糖和能量的摄入,有助于预防肥胖。然而,缺乏支持这种说法的经验数据。目的本研究的目的是评估6个月的低、常规和高饮食甜食对甜味喜好的影响。方法在一项平行组随机对照干预研究中,180名健康成年人(女/男:123/57;年龄:35±15岁;体重指数(kg/m2): 23±3)接受了6个月的饮食建议和每日50%的能量需求,其中7%(低甜味暴露,n = 61)、35%(常规甜味暴露,n = 60)或80%(高甜味暴露,n = 59)提供的食物和饮料是甜味的,包括糖、低热量甜味剂、水果和乳制品。在随访前、6个月和4个月时,对甜味喜好、甜味强度感知、食物选择、能量摄入、体重、糖尿病和心血管疾病标志物以及不良事件进行评估。结果在干预期间,各组之间的甜食摄入量存在差异(自我报告的饮食措施(能量百分比,体重百分比):最小χ2(16) = 59.4, P < 0.001;尿中蔗糖、三氯蔗糖和糖精的标记物:最小χ2(10) = 21.0, P = 0.02)。然而,从基线到第6个月,各组之间在甜味喜好(χ2(40) = 37.9, P = 0.56)、甜味强度感知(χ2(40) = 20.7, P = 0.99)、甜食选择(χ2(10) = 10.1, P = 0.43)、能量摄入(χ2(10) = 12.7, P = 0.24)、体重(χ2(10) = 14.3, P = 0.16)、糖尿病和心血管疾病标志物(χ2(10) = 15.9, P = 0.10)或不良事件方面均无差异。干预后,参与者也自发地恢复到甜食摄入量的基线水平。在目前的试验中,改变对甜味食物的接触并没有改变对甜味的喜爱,也没有改变其他结果。这些结果不支持公共卫生建议,即在不考虑能量密度和食物形式等其他相关因素的情况下,减少接触甜味食物。该试验在clinicaltrials.gov注册为NCT04497974。
{"title":"The Sweet Tooth Trial: A Parallel Randomized Controlled Trial Investigating the Effects of A 6-Month Low, Regular, or High Dietary Sweet Taste Exposure on Sweet Taste Liking, and Various Outcomes Related to Food Intake and Weight Status","authors":"Eva M Čad ,&nbsp;Monica Mars ,&nbsp;Leoné Pretorius ,&nbsp;Merel van der Kruijssen ,&nbsp;Claudia S Tang ,&nbsp;Hanne BT de Jong ,&nbsp;Michiel Balvers ,&nbsp;Katherine M Appleton ,&nbsp;Kees de Graaf","doi":"10.1016/j.ajcnut.2025.09.041","DOIUrl":"10.1016/j.ajcnut.2025.09.041","url":null,"abstract":"<div><h3>Background</h3><div>Public health organizations currently recommend lowering the consumption of sweet-tasting foods, on the assumption that a lower exposure to sweet-tasting foods lowers preferences for sweet taste, decreasing sugar and energy intake, and aiding obesity prevention. However, empirical data supporting this narrative are lacking.</div></div><div><h3>Objectives</h3><div>The objective of this study was to assess the effects of a 6-mo low, regular, and high dietary sweet taste exposure on liking for sweet taste.</div></div><div><h3>Methods</h3><div>In a parallel-groups randomized controlled intervention study, 180 healthy adults (female/male: 123/57; aged: 35 ± 15 y; body mass index (in kg/m<sup>2</sup>): 23 ± 3) were provided with dietary advice and ∼50% daily energy needs for 6 mo, where 7% (low sweet taste exposure, <em>n</em> = 61), 35% (regular sweet taste exposure, <em>n</em> = 60), or 80% (high sweet taste exposure, <em>n</em> = 59) provided foods and beverages were sweet tasting from sugars, low-calorie sweeteners, fruits and dairy. Before, at 6 mo, and at a 4-mo follow-up, sweet taste liking, sweet taste intensity perception, food choice, energy intake, body weight, markers for diabetes and cardiovascular disease, and adverse events were assessed.</div></div><div><h3>Results</h3><div>Sweet food consumption varied between groups over the intervention period (self-reported dietary measures (percentage energy, percentage weight): smallest χ<sup>2</sup>(16) = 59.4, <em>P</em> &lt; 0.001; urinary markers for sucrose, sucralose, and saccharin: smallest χ<sup>2</sup>(10) = 21.0, <em>P</em> = 0.02). However, from baseline to month 6, no differences between groups were found in sweet taste liking ( χ<sup>2</sup>(40) = 37.9, <em>P</em> = 0.56), sweet taste intensity perception (χ<sup>2</sup>(40) = 20.7, <em>P</em> = 0.99), sweet food choice (χ<sup>2</sup>(10) = 10.1, <em>P</em> = 0.43), energy intake (χ<sup>2</sup>(10) = 12.7, <em>P</em> = 0.24), body weight (χ<sup>2</sup>(10) = 14.3, <em>P</em> = 0.16), markers for diabetes and cardiovascular disease (largest χ<sup>2</sup>(10) = 15.9, <em>P</em> = 0.10) or adverse events. After the intervention, participants also spontaneously returned to baseline levels of sweet food intake.</div></div><div><h3>Conclusions</h3><div>In the current trial, altering exposure to sweet-tasting foods did not change sweet taste liking, nor other outcomes. These results do not support public health advice to reduce exposure to sweet-tasting foods, independent of other relevant factors such as energy density and food form.</div><div>This trial was registered at <span><span>clinicaltrials.gov</span><svg><path></path></svg></span> as NCT04497974.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101073"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145876758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human milk composition is associated with maternal overweight/obesity and low milk supply, with implications for infant weight outcomes: a cross-sectional study 母乳成分与母亲超重/肥胖和母乳供应不足有关,并影响婴儿体重结局:一项横断面研究。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.015
Xuehua Jin , Ashleigh H Warden , Ching Tat Lai , Sharon L Perrella , Jacki L McEachran , Nicolas L Taylor , Zoya Gridneva , Donna T Geddes

Background

Low milk supply (LMS) is a major barrier to exclusive and continued lactation. Maternal factors such as overweight/obesity (OW) and gestational diabetes mellitus may contribute to LMS and alter human milk (HM) composition, affecting infant growth.

Objectives

This cross-sectional study examined associations of HM components with LMS and maternal factors, and relationships between infant milk intake and weight outcomes.

Methods

Twenty-four-hour milk production was measured at 1–6 mo postpartum using the test-weigh method. HM samples, demographic, obstetric, and infant data were collected from 225 participants. Macronutrients (fat, protein, lactose, and glucose) and hormones (estrone, estradiol, progesterone, leptin, adiponectin, and insulin) were analyzed.

Results

Maternal OW was associated with higher concentrations of HM fat [β = 5.2; 95% confidence interval (CI): 6.5 × 10−3, 10.4], leptin (β = 197.4; 95% CI: 125.8, 269.1), insulin (β = 5.9; 95% CI: 2.5, 9.2), and higher infant intake of leptin (β = 135.9; 95% CI: 86.3, 185.4) and insulin (β = 3.2; 95% CI: 1.3, 5.0). In the LMS group, despite higher concentrations of HM protein, lactose, insulin, estrone, and progesterone, infant total intakes of fat (β = −9.5; 95% CI: −1.4, −5.4), carbohydrates (β = −6.0; 95% CI: −10.2, −1.8), estrone (β = −9.9; 95% CI: −14.5, −5.4), estradiol (β = −3.5; 95% CI: −5.1, −1.9), leptin (β = −55.9; 95% CI: −109.0, −2.7), and adiponectin (β = −3.9; 95% CI: −6.0, −1.7) were lower. Additionally, infant carbohydrates (β = 11.5 × 10−3; 95% CI: 4.6 × 10−3, 18.4 × 10−3), energy (β = 1.0 × 10−3; 95% CI: 0.3 × 10−3, 1.6 × 10−3), and 24-h total intakes (β = 1.7 × 10−3; 95% CI: 1.1 × 10−3, 2.4 × 10−3) were positively associated with infant weight-for-age z-score.

Conclusions

Maternal OW influences HM composition and infant milk intake. LMS impacts infant weight gain by limiting milk volume, underscoring the importance of timely LMS detection to ensure adequate infant nutrition.
背景:低奶供应(LMS)是排他和持续哺乳的主要障碍。母体因素如超重/肥胖(OW)和妊娠期糖尿病可能导致LMS,改变母乳(HM)成分,影响婴儿生长。目的:本横断面研究考察了HM成分与LMS和母体因素的关联,以及婴儿牛奶摄入量与体重结局之间的关系。方法:产后1 ~ 6个月采用试重法测定24小时产奶量。从225名参与者中收集了HM样本、人口统计、产科和婴儿数据。宏量营养素(脂肪、蛋白质、乳糖和葡萄糖)和激素(雌酮、雌二醇、黄体酮、瘦素、脂联素和胰岛素)进行了分析。结果:母体OW与较高的HM脂肪浓度相关[β = 5.2;95%可信区间(CI): 6.5 × 10- 3,10.4],瘦素(β = 197.4; 95% CI: 125.8, 269.1),胰岛素(β = 5.9; 95% CI: 2.5, 9.2),以及婴儿摄入更多瘦素(β = 135.9; 95% CI: 86.3, 185.4)和胰岛素(β = 3.2; 95% CI: 1.3, 5.0)。在LMS组中,尽管HM蛋白、乳糖、胰岛素、雌酮和黄体酮浓度较高,但婴儿脂肪(β = -9.5; 95% CI: -1.4, -5.4)、碳水化合物(β = -6.0; 95% CI: -10.2, -1.8)、雌酮(β = -9.9; 95% CI: -14.5, -5.4)、雌二醇(β = -3.5; 95% CI: -5.1, -1.9)、瘦素(β = -55.9; 95% CI: -109.0, -2.7)和脂联素(β = -3.9; 95% CI: -6.0, -1.7)的总摄入量较低。此外,婴儿碳水化合物(β = 11.5 × 10-3; 95% CI: 4.6 × 10-3, 18.4 × 10-3)、能量(β = 1.0 × 10-3; 95% CI: 0.3 × 10-3, 1.6 × 10-3)和24小时总摄入量(β = 1.7 × 10-3; 95% CI: 1.1 × 10-3, 2.4 × 10-3)与婴儿年龄体重z-score呈正相关。结论:母亲OW影响HM组成和婴儿母乳摄入量。LMS通过限制奶量影响婴儿体重增加,强调及时检测LMS以确保婴儿充足营养的重要性。
{"title":"Human milk composition is associated with maternal overweight/obesity and low milk supply, with implications for infant weight outcomes: a cross-sectional study","authors":"Xuehua Jin ,&nbsp;Ashleigh H Warden ,&nbsp;Ching Tat Lai ,&nbsp;Sharon L Perrella ,&nbsp;Jacki L McEachran ,&nbsp;Nicolas L Taylor ,&nbsp;Zoya Gridneva ,&nbsp;Donna T Geddes","doi":"10.1016/j.ajcnut.2025.10.015","DOIUrl":"10.1016/j.ajcnut.2025.10.015","url":null,"abstract":"<div><h3>Background</h3><div>Low milk supply (LMS) is a major barrier to exclusive and continued lactation. Maternal factors such as overweight/obesity (OW) and gestational diabetes mellitus may contribute to LMS and alter human milk (HM) composition, affecting infant growth.</div></div><div><h3>Objectives</h3><div>This cross-sectional study examined associations of HM components with LMS and maternal factors, and relationships between infant milk intake and weight outcomes.</div></div><div><h3>Methods</h3><div>Twenty-four-hour milk production was measured at 1–6 mo postpartum using the test-weigh method. HM samples, demographic, obstetric, and infant data were collected from 225 participants. Macronutrients (fat, protein, lactose, and glucose) and hormones (estrone, estradiol, progesterone, leptin, adiponectin, and insulin) were analyzed.</div></div><div><h3>Results</h3><div>Maternal OW was associated with higher concentrations of HM fat [<em>β</em> = 5.2; 95% confidence interval (CI): 6.5 × 10<sup>−3</sup>, 10.4], leptin (<em>β</em> = 197.4; 95% CI: 125.8, 269.1), insulin (<em>β</em> = 5.9; 95% CI: 2.5, 9.2), and higher infant intake of leptin (<em>β</em> = 135.9; 95% CI: 86.3, 185.4) and insulin (<em>β</em> = 3.2; 95% CI: 1.3, 5.0). In the LMS group, despite higher concentrations of HM protein, lactose, insulin, estrone, and progesterone, infant total intakes of fat (<em>β</em> = −9.5; 95% CI: −1.4, −5.4), carbohydrates (<em>β</em> = −6.0; 95% CI: −10.2, −1.8), estrone (<em>β</em> = −9.9; 95% CI: −14.5, −5.4), estradiol (<em>β</em> = −3.5; 95% CI: −5.1, −1.9), leptin (<em>β</em> = −55.9; 95% CI: −109.0, −2.7), and adiponectin (<em>β</em> = −3.9; 95% CI: −6.0, −1.7) were lower. Additionally, infant carbohydrates (<em>β</em> = 11.5 × 10<sup>−3</sup>; 95% CI: 4.6 × 10<sup>−3</sup>, 18.4 × 10<sup>−3</sup>), energy (<em>β</em> = 1.0 × 10<sup>−3</sup>; 95% CI: 0.3 × 10<sup>−3</sup>, 1.6 × 10<sup>−3</sup>), and 24-h total intakes (<em>β</em> = 1.7 × 10<sup>−3</sup>; 95% CI: 1.1 × 10<sup>−3</sup>, 2.4 × 10<sup>−3</sup>) were positively associated with infant weight-for-age <em>z</em>-score.</div></div><div><h3>Conclusions</h3><div>Maternal OW influences HM composition and infant milk intake. LMS impacts infant weight gain by limiting milk volume, underscoring the importance of timely LMS detection to ensure adequate infant nutrition.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101098"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma fatty acids and the likelihood of healthy aging: a prospective cohort study 血浆脂肪酸与健康衰老的可能性:一项前瞻性队列研究。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.11.002
Jie-Qiong Lyu , Meng-Yuan Miao , Fei Fang , Xiu-Ying Cai , Zhong-Yue Liu , Yu-Wen Qian , Ji-Mei Gu , Jing Yang , Li-Qiang Qin , Chenglin Song , Qi Fang , Guo-Chong Chen

Background

Although circulating fatty acids (FAs) are associated with the development of major chronic diseases (MCDs), their relationships with healthy longevity remain unclear.

Objectives

The study aims to examine the relationships between specific plasma FAs and the odds of healthy aging.

Methods

This prospective cohort study included 15,333 participants aged 64 y or older who were free of MCDs at baseline. Exposures were relative levels of different FAs (% total FAs) in the plasma. The primary outcome was healthy aging, defined as survival to age 80 without developing MCDs during the follow-up. Multivariable logistic regression models were used to calculate odds ratio (OR) and 95% confidence interval (CI) of healthy aging associated with specific FAs. Causal mediation analyses were conducted on biomarkers related to age acceleration or several other biological pathways.

Results

A total of 9291 participants achieved healthy aging. Saturated or monounsaturated FAs were not associated with healthy aging. Relatively higher levels of polyunsaturated FAs (PUFAs) were associated with higher odds of healthy aging (OR comparing the extreme quartiles: 1.32; 95% CI: 1.04, 1.68; P-trend < 0.001), with similar associations for n-3 PUFAs and n-6 PUFAs. Docosahexaenoic acid (DHA), non-DHA n-3 PUFAs, and linoleic acid (LA), but not non-LA n-6 PUFAs, were positively associated with the odds of healthy aging. A higher ratio of n-6/n-3 PUFAs was associated with lower odds of healthy aging (OR: 0.88; 95% CI: 0.79, 0.97). Six biomarkers were identified as significant mediators for the above associations, with age acceleration explaining 16.1% and 37.4% of the relationships of n-3 PUFAs and n-6/n-3 PUFAs ratio with healthy aging, respectively.

Conclusions

Relatively higher levels of plasma PUFAs, including n-3 PUFAs (both DHA and the non-DHA components) and n-6 PUFAs (LA but not the non-LA components), are associated with higher odds of healthy aging, potentially through retarding the biological aging processes.
背景:虽然循环脂肪酸(FAs)与主要慢性疾病(MCDs)的发展有关,但它们与健康寿命的关系尚不清楚。目的:探讨特异性血浆FAs与健康衰老的关系。方法:这项前瞻性队列研究包括15333名年龄在64岁或以上的参与者,他们在基线时没有mcd。暴露是血浆中不同FAs的相对水平(占总FAs的百分比)。主要结局是健康老龄化,定义为在随访期间存活至80岁且未发生mcd。采用多变量logistic回归模型计算健康老龄化与特异性FAs相关的比值比(OR)和95%置信区间(CI)。对与年龄加速或其他几种生物学途径相关的生物标志物进行了因果中介分析。结果:9291名受试者实现健康老龄化。饱和或单不饱和脂肪酸与健康衰老无关。相对较高水平的多不饱和脂肪酸(PUFAs)与较高的健康衰老几率相关(OR比较极端四分位数:1.32;95% CI: 1.04, 1.68; p趋势< 0.001),n-3 PUFAs和n-6 PUFAs的相关性相似。二十二碳六烯酸(DHA)、非DHA n-3 PUFAs和亚油酸(LA)与健康衰老的几率呈正相关,而非LA n-6 PUFAs与健康衰老的几率呈正相关。较高的n-6/n-3 PUFAs比例与较低的健康衰老几率相关(OR: 0.88; 95% CI: 0.79, 0.97)。6种生物标志物被确定为上述关联的重要中介,年龄加速分别解释了16.1%和37.4%的n-3 PUFAs和n-6/n-3 PUFAs比值与健康衰老的关系。结论:相对较高水平的血浆PUFAs,包括n-3 PUFAs(包括DHA和非DHA成分)和n-6 PUFAs (LA但不包括非LA成分),与较高的健康衰老几率相关,可能通过延缓生物衰老过程。
{"title":"Plasma fatty acids and the likelihood of healthy aging: a prospective cohort study","authors":"Jie-Qiong Lyu ,&nbsp;Meng-Yuan Miao ,&nbsp;Fei Fang ,&nbsp;Xiu-Ying Cai ,&nbsp;Zhong-Yue Liu ,&nbsp;Yu-Wen Qian ,&nbsp;Ji-Mei Gu ,&nbsp;Jing Yang ,&nbsp;Li-Qiang Qin ,&nbsp;Chenglin Song ,&nbsp;Qi Fang ,&nbsp;Guo-Chong Chen","doi":"10.1016/j.ajcnut.2025.11.002","DOIUrl":"10.1016/j.ajcnut.2025.11.002","url":null,"abstract":"<div><h3>Background</h3><div>Although circulating fatty acids (FAs) are associated with the development of major chronic diseases (MCDs), their relationships with healthy longevity remain unclear.</div></div><div><h3>Objectives</h3><div>The study aims to examine the relationships between specific plasma FAs and the odds of healthy aging.</div></div><div><h3>Methods</h3><div>This prospective cohort study included 15,333 participants aged 64 y or older who were free of MCDs at baseline. Exposures were relative levels of different FAs (% total FAs) in the plasma. The primary outcome was healthy aging, defined as survival to age 80 without developing MCDs during the follow-up. Multivariable logistic regression models were used to calculate odds ratio (OR) and 95% confidence interval (CI) of healthy aging associated with specific FAs. Causal mediation analyses were conducted on biomarkers related to age acceleration or several other biological pathways.</div></div><div><h3>Results</h3><div>A total of 9291 participants achieved healthy aging. Saturated or monounsaturated FAs were not associated with healthy aging. Relatively higher levels of polyunsaturated FAs (PUFAs) were associated with higher odds of healthy aging (OR comparing the extreme quartiles: 1.32; 95% CI: 1.04, 1.68; <em>P</em>-trend &lt; 0.001), with similar associations for n-3 PUFAs and n-6 PUFAs. Docosahexaenoic acid (DHA), non-DHA n-3 PUFAs, and linoleic acid (LA), but not non-LA n-6 PUFAs, were positively associated with the odds of healthy aging. A higher ratio of n-6/n-3 PUFAs was associated with lower odds of healthy aging (OR: 0.88; 95% CI: 0.79, 0.97). Six biomarkers were identified as significant mediators for the above associations, with age acceleration explaining 16.1% and 37.4% of the relationships of n-3 PUFAs and n-6/n-3 PUFAs ratio with healthy aging, respectively.</div></div><div><h3>Conclusions</h3><div>Relatively higher levels of plasma PUFAs, including n-3 PUFAs (both DHA and the non-DHA components) and n-6 PUFAs (LA but not the non-LA components), are associated with higher odds of healthy aging, potentially through retarding the biological aging processes.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101109"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genotype-informed magnesium supplementation and rectal-niche microbial shifts: clarifying multiplicity, compositionality, and local vitamin D biology 基因型通知镁补充和直肠生态位微生物转移:澄清多样性,组合性和局部维生素D生物学。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.018
Aiyu Guan
{"title":"Genotype-informed magnesium supplementation and rectal-niche microbial shifts: clarifying multiplicity, compositionality, and local vitamin D biology","authors":"Aiyu Guan","doi":"10.1016/j.ajcnut.2025.10.018","DOIUrl":"10.1016/j.ajcnut.2025.10.018","url":null,"abstract":"","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101101"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Environmental enteric dysfunction, systemic inflammation, growth hormones, and linear growth in infants in western Kenya: a prospective observational cohort study 肯尼亚西部婴儿的环境性肠功能障碍、全身炎症、生长激素和线性生长:一项前瞻性观察队列研究。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.012
Mary Iwaret Otiti , James Dodd , Alloys K’Oloo , Micah June , Miriam Chomba , Duolao Wang , Kephas Otieno , Simon Kariuki , Feiko Ter Kuile , Stephen Allen

Background

Environmental enteric dysfunction is associated with chronic systemic inflammation that results in growth hormone resistance and impaired growth although associations differ between settings.

Objectives

We aimed to describe the time of onset and progression of intestinal pathology and explore associations between biomarkers of environmental enteric dysfunction, systemic inflammation, growth hormones, and linear growth in infants in western Kenya.

Methods

In this prospective, observational cohort study, analysis is limited to infants recruited to the control arm (no intervention) of the PROSYNK trial between 28 October, 2020, and 13 January, 2022. Biomarkers of environmental enteric dysfunction, systemic inflammation, growth hormones, and infant length were measured at 6 wk and 3, 6, and 12 mo. Associations between biomarkers, growth hormones, and linear growth between time points were explored.

Results

In 149 infants at age 6 wk, fecal myeloperoxidase (a biomarker of intestinal inflammation) was raised (≥0.2 mg/dL) in 47 of 143 (32.9%) and fecal α1-antitrypsin (intestinal permeability; ≥26.8 mg/dL) in 26 of 142 (18.3%) infants. Chronic systemic inflammation (plasma α1-acid glycoprotein, >1 g/dL) occurred from age 3 mo (33/140 infants; 23.6%). Once detected, intestinal inflammation, increased intestinal permeability, and chronic systemic inflammation persisted in most infants. Fecal myeloperoxidase, fecal α1-antitrypsin, and plasma intestinal fatty acid–binding protein (intestinal integrity) were significantly positively associated with chronic systemic inflammation at some time points. Chronic systemic inflammation was significantly negatively associated with insulin-like growth factor 1 and insulin-like growth factor–binding protein 3 at 3, 6, and 12 mo. In multiple regression analysis, fecal α1-antitrypsin at age 6 mo was negatively associated with subsequent change in length-for-age z-score (n = 124; coefficient: −0.32; 95% CI: −0.50, −0.13; P = 0.001).

Conclusions

Targeting young infants with environmental enteric dysfunction, and especially increased gut permeability, may prevent or ameliorate chronic systemic inflammation and improve growth and development in infants in western Kenya.
The PROSYNK trial was registered at the Pan African Clinical Trials Registry (https://pactr.samrc.ac.za/) as PACTR202003893276712 (https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9798).
背景:环境性肠功能障碍与导致生长激素抵抗和生长受损的慢性全身性炎症有关,尽管不同环境的相关性不同。目的:我们旨在描述肠道病理的发病和进展时间,并探索环境肠功能障碍、全身性炎症、生长激素和肯尼亚西部婴儿线性生长的生物标志物之间的联系。方法:在这项前瞻性观察性队列研究中,分析仅限于在2020年10月28日至2022年1月13日期间招募到PROSYNK试验对照组(无干预)的婴儿。在6周、3,6和12个月时测量环境肠功能障碍、全身性炎症、生长激素和婴儿身高的生物标志物。探索生物标志物、生长激素和时间点之间的线性生长之间的关系。结果:在149名6周龄婴儿中,143名婴儿中有47名(32.9%)的粪便髓过氧化物酶(肠道炎症的生物标志物)升高(≥0.2 mg/dL), 142名婴儿中有26名(18.3%)的粪便α1-抗胰蛋白酶(肠通透性;≥26.8 mg/dL)升高。慢性全身性炎症(血浆α1-酸性糖蛋白,>.1 g/dL)发生于3个月(33/140,23.6%)。一旦发现,大多数婴儿的肠道炎症、肠通透性增加和慢性全身性炎症持续存在。在某些时间点,粪便髓过氧化物酶、粪便α1-抗胰蛋白酶和血浆肠道脂肪酸结合蛋白(肠道完整性)与慢性全身炎症呈显著正相关。慢性全身性炎症与胰岛素样生长因子1和胰岛素样生长因子结合蛋白3在3、6和12个月时呈显著负相关。在多元回归分析中,6个月时的粪便α1-抗胰蛋白酶与随后的年龄长度z-score变化呈负相关(n = 124,系数:-0.32,95% CI: -0.50, -0.13, P = 0.001)。结论:针对肯尼亚西部患有环境性肠功能障碍的婴儿,特别是肠道通透性增加的婴儿,可能预防或改善慢性全身性炎症,并改善婴儿的生长发育。PROSYNK试验已在泛非临床试验注册中心(https://pactr.samrc.ac.za/)注册为PACTR202003893276712 (https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9798)。
{"title":"Environmental enteric dysfunction, systemic inflammation, growth hormones, and linear growth in infants in western Kenya: a prospective observational cohort study","authors":"Mary Iwaret Otiti ,&nbsp;James Dodd ,&nbsp;Alloys K’Oloo ,&nbsp;Micah June ,&nbsp;Miriam Chomba ,&nbsp;Duolao Wang ,&nbsp;Kephas Otieno ,&nbsp;Simon Kariuki ,&nbsp;Feiko Ter Kuile ,&nbsp;Stephen Allen","doi":"10.1016/j.ajcnut.2025.10.012","DOIUrl":"10.1016/j.ajcnut.2025.10.012","url":null,"abstract":"<div><h3>Background</h3><div>Environmental enteric dysfunction is associated with chronic systemic inflammation that results in growth hormone resistance and impaired growth although associations differ between settings.</div></div><div><h3>Objectives</h3><div>We aimed to describe the time of onset and progression of intestinal pathology and explore associations between biomarkers of environmental enteric dysfunction, systemic inflammation, growth hormones, and linear growth in infants in western Kenya.</div></div><div><h3>Methods</h3><div>In this prospective, observational cohort study, analysis is limited to infants recruited to the control arm (no intervention) of the PROSYNK trial between 28 October, 2020, and 13 January, 2022. Biomarkers of environmental enteric dysfunction, systemic inflammation, growth hormones, and infant length were measured at 6 wk and 3, 6, and 12 mo. Associations between biomarkers, growth hormones, and linear growth between time points were explored.</div></div><div><h3>Results</h3><div>In 149 infants at age 6 wk, fecal myeloperoxidase (a biomarker of intestinal inflammation) was raised (≥0.2 mg/dL) in 47 of 143 (32.9%) and fecal α<sub>1</sub>-antitrypsin (intestinal permeability; ≥26.8 mg/dL) in 26 of 142 (18.3%) infants. Chronic systemic inflammation (plasma α<sub>1</sub>-acid glycoprotein, &gt;1 g/dL) occurred from age 3 mo (33/140 infants; 23.6%). Once detected, intestinal inflammation, increased intestinal permeability, and chronic systemic inflammation persisted in most infants. Fecal myeloperoxidase, fecal α<sub>1</sub>-antitrypsin, and plasma intestinal fatty acid–binding protein (intestinal integrity) were significantly positively associated with chronic systemic inflammation at some time points. Chronic systemic inflammation was significantly negatively associated with insulin-like growth factor 1 and insulin-like growth factor–binding protein 3 at 3, 6, and 12 mo. In multiple regression analysis, fecal α<sub>1</sub>-antitrypsin at age 6 mo was negatively associated with subsequent change in length-for-age <em>z</em>-score (<em>n</em> = 124; coefficient: −0.32; 95% CI: −0.50, −0.13; <em>P</em> = 0.001).</div></div><div><h3>Conclusions</h3><div>Targeting young infants with environmental enteric dysfunction, and especially increased gut permeability, may prevent or ameliorate chronic systemic inflammation and improve growth and development in infants in western Kenya.</div><div>The PROSYNK trial was registered at the Pan African Clinical Trials Registry (<span><span>https://pactr.samrc.ac.za/</span><svg><path></path></svg></span>) as PACTR202003893276712 (<span><span>https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9798</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101095"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of hemoglobin measurements from venous and capillary blood from the same individual using HemoCue 301 and automated hematology analyzer in a cross-sectional community-based study in India 在印度的一项横断面社区研究中,使用HemoCue 301和自动血液学分析仪比较同一个体的静脉血和毛细血管血的血红蛋白测量值。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.11.009
V Sudhakar Reddy , Samarasimha N Reddy , Hemant Mahajan , Karthikeyan Ramanujam , G Bhanuprakash Reddy , Jagajeevan Babu Geddam , Challa Sairam , Mahesh Kumar Mummadi , Jayachandra Kadiyam , Venkata Raji G Reddy , Sai Santhosh V , Jayaprakash Ithadi , Shyam Sunder Katha , Rajitha Triveni

Background

Accurate measurement of hemoglobin (Hb) is essential for diagnosing anemia, a widespread public health concern. Automated hematology analyzer (AHA) offers high accuracy using venous blood, whereas HemoCue (HC) 301 provides rapid point-of-care (POC) results often from capillary samples. Differences between capillary and venous blood can influence Hb values, impacting anemia prevalence estimates and public health policies.

Objectives

We compared Hb measurements from venous and capillary blood using the HC 301 [venous blood Hb analyzed by HC 301 (HC-V) and capillary blood Hb analyzed by HC 301 (HC-C)] with the reference method of venous blood analysis using the AHA (AHA-V) in the same participant.

Methods

Venous and capillary blood samples were collected in a community-based cross-sectional survey conducted in Kamrup Metro district, Assam, India, from 837 participants. The study covered all age and sex groups, including 2–5 y children, 6–9 y, 10–19 y, 20–59 y adults, and ≥60 y. Hb concentration was measured using the HC 301 (HC-C and HC-V) and AHA (AHA-V). Diagnostic accuracy was evaluated by comparing the HC 301 (HC-C and HC-V) with the AHA (AHA-V). Hb values were compared using a paired t test, anemia prevalence with McNemar’s test, and method agreement through weighted κ, Lin’s concordance coefficient, and Bland–Altman plots.

Results

The mean Hb difference among all age groups (n = 837) was 0.46 g/dL (AHA-V compared with HC-C), 0.59 g/dL (HC-V compared with HC-C), and −0.13 g/dL (AHA-V compared with HC-V), respectively. Anemia prevalence was highest with HC-C [71.1%, 95% confidence interval (CI): 67.9%, 74.1%] compared with AHA-V (58.9%, 95% CI: 55.5%, 62.2%) and HC-V (55.2%, 95% CI: 51.7%, 58.6%). κ agreement was weaker between AHA-V and HC-C (κ = 0.59, 95% CI: 0.52, 0.65) for all age groups but stronger for AHA-V and HC-V (κ = 0.84, 95% CI: 0.77, 0.91).

Conclusions

HC-C showed higher anemia prevalence and weaker agreement compared with AHA-V, indicating potential overestimation. Anemia prevalence estimated through capillary blood using POC devices in large-scale public health surveys needs cautious interpretation.
背景:血红蛋白(Hb)的准确测量是诊断贫血必不可少的,贫血是一个广泛关注的公共卫生问题。自动血液学分析仪(AHA)使用静脉血提供高精度,而HemoCue 301 (HC)通常从毛细管样品中提供快速的护理点(POC)结果。毛细血管和静脉血之间的差异可以影响Hb值,影响贫血患病率估计和公共卫生政策。目的:我们比较了使用HemoCue 301 (HC-V和HC-C)测量的静脉血和毛细血管血Hb与使用AHA (AHA- v)分析静脉血的参考方法。方法:在印度阿萨姆邦Kamrup Metro区进行的社区横断面调查中收集了837名参与者的静脉和毛细血管血样。研究涵盖了所有年龄和性别群体,包括2-5岁儿童、6-9岁、10-19岁、20-59岁成人和≥60岁。采用HemoCue 301 (HC-C和HC-V)和AHA (AHA- v)测定血红蛋白浓度。通过比较HemoCue 301 (HC-C和HC-V)和AHA (AHA- v)来评估诊断的准确性。使用配对t检验比较Hb值,使用McNemar检验比较贫血发生率,并通过加权kappa (κ)、Lin’s一致性系数和Bland-Altman图比较方法一致性。结果:各年龄组(n=837)的平均Hb差异分别为0.46 g/dL (ha - v vs . HC-C)、0.59 g/dL (HC-V vs . HC-C)和-0.13 g/dL (ha - v vs . HC-V)。与ha - v (58.9%, 95% CI: 55.5-62.2%)和HC-V (55.2%, 95% CI: 51.7-58.6%)相比,HC-C的贫血患病率最高(71.1%,95% CI: 67.9-74.1%)。所有年龄组AHA-V和HC-C之间的Kappa一致性较弱(κ=0.59, 95% CI:0.52-0.65),但AHA-V和HC-V之间的Kappa一致性较强(κ=0.84, 95% CI: 0.77-0.91)。结论:HC-C与ha - v相比,贫血患病率更高,一致性较弱,可能存在高估。在大规模公共卫生调查中使用POC装置通过毛细管血估计贫血患病率需要谨慎解释。
{"title":"Comparison of hemoglobin measurements from venous and capillary blood from the same individual using HemoCue 301 and automated hematology analyzer in a cross-sectional community-based study in India","authors":"V Sudhakar Reddy ,&nbsp;Samarasimha N Reddy ,&nbsp;Hemant Mahajan ,&nbsp;Karthikeyan Ramanujam ,&nbsp;G Bhanuprakash Reddy ,&nbsp;Jagajeevan Babu Geddam ,&nbsp;Challa Sairam ,&nbsp;Mahesh Kumar Mummadi ,&nbsp;Jayachandra Kadiyam ,&nbsp;Venkata Raji G Reddy ,&nbsp;Sai Santhosh V ,&nbsp;Jayaprakash Ithadi ,&nbsp;Shyam Sunder Katha ,&nbsp;Rajitha Triveni","doi":"10.1016/j.ajcnut.2025.11.009","DOIUrl":"10.1016/j.ajcnut.2025.11.009","url":null,"abstract":"<div><h3>Background</h3><div>Accurate measurement of hemoglobin (Hb) is essential for diagnosing anemia, a widespread public health concern. Automated hematology analyzer (AHA) offers high accuracy using venous blood, whereas HemoCue (HC) 301 provides rapid point-of-care (POC) results often from capillary samples. Differences between capillary and venous blood can influence Hb values, impacting anemia prevalence estimates and public health policies.</div></div><div><h3>Objectives</h3><div>We compared Hb measurements from venous and capillary blood using the HC 301 [venous blood Hb analyzed by HC 301 (HC-V) and capillary blood Hb analyzed by HC 301 (HC-C)] with the reference method of venous blood analysis using the AHA (AHA-V) in the same participant.</div></div><div><h3>Methods</h3><div>Venous and capillary blood samples were collected in a community-based cross-sectional survey conducted in Kamrup Metro district, Assam, India, from 837 participants. The study covered all age and sex groups, including 2–5 y children, 6–9 y, 10–19 y, 20–59 y adults, and ≥60 y. Hb concentration was measured using the HC 301 (HC-C and HC-V) and AHA (AHA-V). Diagnostic accuracy was evaluated by comparing the HC 301 (HC-C and HC-V) with the AHA (AHA-V). Hb values were compared using a paired <em>t</em> test, anemia prevalence with McNemar’s test, and method agreement through weighted κ, Lin’s concordance coefficient, and Bland–Altman plots.</div></div><div><h3>Results</h3><div>The mean Hb difference among all age groups (<em>n</em> = 837) was 0.46 g/dL (AHA-V compared with HC-C), 0.59 g/dL (HC-V compared with HC-C), and −0.13 g/dL (AHA-V compared with HC-V), respectively. Anemia prevalence was highest with HC-C [71.1%, 95% confidence interval (CI): 67.9%, 74.1%] compared with AHA-V (58.9%, 95% CI: 55.5%, 62.2%) and HC-V (55.2%, 95% CI: 51.7%, 58.6%). κ agreement was weaker between AHA-V and HC-C (κ = 0.59, 95% CI: 0.52, 0.65) for all age groups but stronger for AHA-V and HC-V (κ = 0.84, 95% CI: 0.77, 0.91).</div></div><div><h3>Conclusions</h3><div>HC-C showed higher anemia prevalence and weaker agreement compared with AHA-V, indicating potential overestimation. Anemia prevalence estimated through capillary blood using POC devices in large-scale public health surveys needs cautious interpretation.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101119"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145574490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Steps toward better understanding the role of dietary intake on development of complications in people with type 2 diabetes 进一步了解饮食摄入对2型糖尿病患者并发症发展的作用。
IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-01-01 DOI: 10.1016/j.ajcnut.2025.10.021
Daniel B Ibsen
{"title":"Steps toward better understanding the role of dietary intake on development of complications in people with type 2 diabetes","authors":"Daniel B Ibsen","doi":"10.1016/j.ajcnut.2025.10.021","DOIUrl":"10.1016/j.ajcnut.2025.10.021","url":null,"abstract":"","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"123 1","pages":"Article 101104"},"PeriodicalIF":6.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Clinical Nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1